A detailed history of Crewe Advisors LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Crewe Advisors LLC holds 253 shares of LMAT stock, worth $23,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253
Previous 67 277.61%
Holding current value
$23,189
Previous $4,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$62.62 - $83.59 $11,647 - $15,547
186 Added 277.61%
253 $20,000
Q1 2024

May 13, 2024

BUY
$54.0 - $71.06 $3,618 - $4,761
67 New
67 $4,000
Q2 2022

Aug 02, 2022

BUY
$39.05 - $47.85 $16,986 - $20,814
435 New
435 $20,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.01B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.